-
Looking for biomarkers that predict recurrent GBM prognosis with the treatment of bevalbea monoantigens
Time of Update: 2020-05-31
Bevalbezumab is a monoclonal antibody for vascular endothelial growth factor (VEGF) and is commonly used in the treatment of patients with recurrent glioblastoma (GBM) Determining biomarkers that pred
-
Deep imaging histology computing predicts the prognosis of GBM patients
Time of Update: 2020-05-31
Study background glioblastoma (GBM) is a highly invasive growth of malignant brain tumors, belongto in WHO IV grade Currently, the most common method of neuroradiology for diagnosing GBM is MRI imagi
-
The prognosis of gamma knife treatment of hair cell-type astrocyteoma
Time of Update: 2020-05-31
Currently, the preferred treatment for haircell-type astrocytoma (PA) is surgery to remove tumours to the maximum extent possible within a safe range For haircell-type atomosomas that are left, relaps
-
Natural retreat of slope spinal tumors
Time of Update: 2020-05-31
Spinal stoma is a residual tissue that originates from the embryo's spinal cable The most common sites are 50% in the tibia, 30% at the base of the skull and 15% in the spine There have been reports i
-
Ivemos and octreotides to treat recurrent meningiomas
Time of Update: 2020-05-31
Background growth inhibitor type 2 receptor expression enhancement and Pi3K/Akt/mTOR pathway activation In in vitro experiments, the combination of mTOR inhibitor sylvemer and growth inhibitor octreo
-
Atypical histone H3 mutation in spinal diffuse glioma
Time of Update: 2020-05-31
Background coding histoneH3 variants H3.3 and H3.1 Genes H3F3A and HIST1H3B gene somatic cell mutations are important genetic drivers of diffuse glioma in children and adults The p.K27M mutation in t
-
Regulation of tumor-related macrophages on the development of glioma
Time of Update: 2020-05-31
Tumor-related macrophages (tumor-associated macrophages, TAM) play an important role in the immune response of tumors, but it is not clear how TAM and T cells regulate immune function in tumor microen
-
Prospects for targeted treatment of glazed cranial pharynx tumors
Time of Update: 2020-05-31
Study background glazed cranial pharynx tumor (adamantinomatous craniopharynoma, ACP) is a type of benign heterogeneous brain tumor formed by rathke's pouch residue in the saddle or saddle area Tumor
-
Radiotherapy-binding anti-PD-L1 antibody activates macrophages to induce remote effects of GBM treatment
Time of Update: 2020-05-31
Most glioblastomas (GBMs) recur in the 2cm range of the original tumor after surgery and standard chemotherapy Therefore, a significant improvement in the survival of GBM patients may require the use
-
M2 macrophages in glioma associated with local and systemic immunosuppression in patients
Time of Update: 2020-05-31
Background glioblastoma (GBM) is the most common and malignant primary brain tumor in the central nervous system, accounting for 56% of all gliomas The immunosuppression caused by glioma cells is one
-
The length of lymphocytes telomerase is associated with the risk of meningioma
Time of Update: 2020-05-31
Telomerase is a basic nucleoprotein reverse transcriptase that is responsible for the repair and prolongation of telomeres in cells Single nucleotide polymorphism sites (SNPs) associated with telomere
-
intracranial multiple meningocomy
Time of Update: 2020-05-31
Meningioma, which originated in the cobweb synocoscosin cap of the membrane of the membrane, ( arachnoidal cap cell ) and is a type of common intracranial primary tumor , with an annual incidence
-
Rapid unlabeled identification of brain tumor biopsy tissue using near-infrared Raman spectra and fluorescence spectra
Time of Update: 2020-05-31
In the past few decades, the application of neuroimaging, brain function positioning, neuronavigation and fluorescence technology has improved the recognition of malignant brain tumors, and can expand
-
Transcortical removal of island leaf glioma
Time of Update: 2020-05-31
The transcortical inlet or the external split into the road is the main way to remove the island leaf glioma Professor Wu Jinsong, of Neurosurgery at Huashan Hospital in Shanghai, and professor Wu Ji
-
The therapeutic effect of chemotherapy on central neuroblastoma
Time of Update: 2020-05-31
Central neuroblastoma (CN) is a rare central nervous system tumor that is a WHO II grade and generally has a good prognosis The tumor is well-developed in the lateral ventricle and the triencephaliary
-
CD133-AKT-Wnt signal axis drives GBM stem cells
Time of Update: 2020-05-31
Cell surface markers play an important role in identifying tumor types and drug screening CD133 was originally used as a marker for identifying self-renewing hematopoietic and neural stem cell subgrou
-
PRL/PRLR Can Advance Brain Glioma
Time of Update: 2020-05-31
Background prolactin (prolactin, PRL) is a peptide hormone secreted from the pituitary front alve, and in addition to the pituitary front, organs that secrete PRL, including the breast, prostate, bra
-
CIMPACT-NOW Round 1 Updated Key Points for Brain Tumor Diagnosis
Time of Update: 2020-05-31
The purpose of the Committee on Molecular Information and Practice Methods for the Classification of Central Nervous System (CNS) Tumors (the Consortium to Inform Molecular and Practical Approaches to
-
1H-MRS identifies hemispheric diffuse gliomaIDH and TERTp mutation states
Time of Update: 2020-05-31
Background molecular markers play an important role in the study of glioma biology Specifically, isocitic acid dehydrogenase (IDH), telomerase reverse transcriptase gene promoter (TERTp), the X chain
-
TMZ-assisted chemotherapy combined with MRgFUS destroys blood-brain barrier to treat PATIENTs after GBM
Time of Update: 2020-05-31
Background the main cause of death of glioblastoma (GBM) patients after treatment was the recurrence and progression of the tumor Usually the tumor recurrence is within 2 cm of the lesions to the edg
